Neoleukin Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Update

NEXT STORY
Merus N.V. Announces Proposed Public Offering of Common Shares
PREV STORY
Arcutis Announces Third Quarter 2021 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rare pigs could provide researchers a more effective way to develop treatments for diabetes

West Lafayette, Indiana, Feb. 15, 2018 (GLOBE NEWSWIRE) -- A unique breed of pig ...

author_avatar
NASDAQ Market News

Chimerix Appoints Heather Knight-Trent, PharmD, as Vice President of Regulatory Affairs

DURHAM, N.C., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company committed ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech’s financial calendar and Annual General Meeting in 2019

FIT Biotech Oy Company release 14.12.2018 at 09:00 AM EET FIT Biotech's financial calendar and Annual ...

author_avatar
NASDAQ Market News